Deficiency of Alpha-1-Antitrypsin
We recommend
Augmentation Therapy of Bronchiectasis Due to AATD – Case Report
Alpha-1-antitrypsin deficiency (AATD) is a rare cause of bronchiectasis unrelated to cystic fibrosis. The role of augmentation therapy with alpha-1-antitrypsin (AAT) in patients with AATD with bronchiectasis without pulmonary emphysema is still unclear. A case report from authors in Heidelberg presents a patient with bronchiectasis based on AATD, where augmentation therapy reduced the number of exacerbations and improved clinical condition.
Repeated Episodes of Respiratory Failure Due to Undiagnosed AAT Deficiency – Case Report
The case report from authors in Naples shows that alpha-1-antitrypsin deficiency (AATD) should be…
Interactive Case Study: AATD – Alpha-1-Antitrypsin Deficiency
We present a case study of a man who was 41 years old at the time of his first contact with a…
No content is currently available on this topic.
Subscribe
Conferences news
Go to records
Go to records
Go to records
Go to records
Most read on this topic
- Augmentation Therapy of Bronchiectasis Due to AATD – Case Report
- Interactive Case Study: AATD – Alpha-1-Antitrypsin Deficiency
- Repeated Episodes of Respiratory Failure Due to Undiagnosed AAT Deficiency – Case Report
Related topic
Interesting links